14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.24 $2.30 Friday, 3rd May 2024 ATOS stock ended at $1.66. This is 9.21% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 11.11% from a day low at $1.53 to a day high of $1.70.
90 days $0.83 $2.30
52 weeks $0.622 $2.30

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
Jan 22, 2021 $1.88 $1.95 $1.66 $1.87 40 071 389
Jan 21, 2021 $1.75 $2.06 $1.47 $1.67 61 340 745
Jan 20, 2021 $1.42 $1.55 $1.28 $1.54 21 233 609
Jan 19, 2021 $1.33 $1.45 $1.29 $1.41 17 170 146
Jan 15, 2021 $1.33 $1.33 $1.13 $1.25 15 462 679
Jan 14, 2021 $1.21 $1.35 $1.19 $1.25 24 679 327
Jan 13, 2021 $1.08 $1.24 $1.07 $1.18 24 125 411
Jan 12, 2021 $1.10 $1.12 $1.01 $1.05 15 580 861
Jan 11, 2021 $0.98 $1.10 $0.93 $1.10 28 620 892
Jan 08, 2021 $0.97 $0.98 $0.93 $0.96 10 930 283
Jan 07, 2021 $0.95 $0.96 $0.92 $0.95 12 214 739
Jan 06, 2021 $0.90 $0.95 $0.88 $0.92 31 572 337
Jan 05, 2021 $0.95 $1.21 $0.95 $1.14 22 521 540
Jan 04, 2021 $0.95 $0.97 $0.89 $0.95 6 803 862
Dec 31, 2020 $0.88 $0.97 $0.87 $0.95 18 330 566
Dec 30, 2020 $0.88 $0.89 $0.86 $0.88 4 001 747
Dec 29, 2020 $0.90 $0.90 $0.86 $0.87 5 602 548
Dec 28, 2020 $0.91 $0.92 $0.88 $0.89 6 450 316
Dec 24, 2020 $0.92 $0.95 $0.88 $0.88 4 787 406
Dec 23, 2020 $0.89 $0.97 $0.86 $0.90 23 967 113
Dec 22, 2020 $0.86 $0.88 $0.84 $0.88 5 847 805
Dec 21, 2020 $0.85 $0.86 $0.83 $0.86 4 450 023
Dec 18, 2020 $0.88 $0.88 $0.84 $0.85 6 405 324
Dec 17, 2020 $0.83 $0.88 $0.81 $0.86 22 911 616
Dec 16, 2020 $0.89 $0.98 $0.87 $0.96 15 737 457
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT